• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Novartis AG (NVS)

    -NYSE
    97.40 Down 1.76(1.77%) Jan 30, 4:01PM EST
    Add to Portfolio
    Prev Close:99.16
    Open:97.90
    Bid:96.00 x 100
    Ask:99.54 x 100
    1y Target Est:104.77
    Beta:0.61
    Next Earnings Date:N/A
    Day's Range:97.39 - 98.52
    52wk Range:77.90 - 102.59
    Volume:1,483,701
    Avg Vol (3m):1,746,400
    Market Cap:233.63B
    P/E (ttm):23.59
    EPS (ttm):4.13
    Div & Yield:2.72 (2.70%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVSDown 1.77%233.63B
    MRKDown 2.92%171.85B
    PFEDown 1.82%196.90B
    SNYDown 1.94%120.95B

    Key Statistics

    Forward P/E (1 yr):17.27
    P/S (ttm):4.46
    Ex-Dividend Date:27-Feb-14

    Analysts

    Annual EPS Est (Dec-15) :5.50
    Quarterly EPS Est (Mar-15) :1.03
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback